Unlocking the Secrets of Obesity Drug Responses
Kilder
- Nature: Clinical application of base editing for treating β-thalassaemia - Nature
- Nature: Synthetic super-enhancers enable precision viral immunotherapy - Nature
- Fiercebiotech: OrbiMed’s Sidewinder slides toward clinic with $137M series B for antibody-drug conjugates - Fierce Biotech
- Bioworld: Sononeu wins $5.2M ARPA-H grant for ultrasound-activated therapeutics - BioWorld News
- Nature: A penicillin-binding protein inhibitor series to target drug-resistant Neisseria gonorrhoeae - Nature
- Nature: Why obesity drugs work better for some people: these genes hold clues - Nature
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.